- Real-life ruxolitinib experience in intermediate-risk myelofibrosis
-
Arikan F, Toptas T, Atagunduz IK, Ercan T, Oruc O, Yilmaz F, Tuglular T
- KMID: 2524092
- Blood Res.
- 2021 Dec;56(4):322-331.
- doi: 10.5045/br.2021.2021101
Background In this retrospective cohort of patients with primary, post-polycythemia vera, or post-essential thrombocythemia myelofibrosis, 57 patients with MF who received ruxolitinib for MF-related symptoms or symptomatic splenomegaly were evaluated. Methods The median... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study
-
Gungorduk , Ertas IE, Ozdemir A, Akkaya E, Telli E, Taskin S, Gokcu M, Guzel AB, Oge T, Akman L, Toptas T, Solmaz U, Dogan A, Terek MC, Sanci M, Ozsaran A, Simsek T, Vardar MA, Yalcin OT, Ozalp S, Yildirim Y, Ortac F
- KMID: 2148498
- Cancer Res Treat.
- 2015 Jul;47(3):480-488.
- doi: 10.4143/crt.2014.058
PURPOSE: The purpose of this study is to evaluate the prognostic role of preoperative neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) and the need for para-aortic... -
- CITED
-
- Close
- SHARE
-
- Close
